Mersana Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Mersana Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $0 as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-11-14
- 2025-09-30: Operating Lease, Liability, Noncurrent $0.00.
- 2025-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2025-03-31: Operating Lease, Liability, Noncurrent $262.00K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $1.29M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $262.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.29M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $2.29M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.27M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.22M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.15M 10-K · filed 2025-03-03 |
| 2023-09-30 | $6.05M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.93M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $7.77M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $8.57M 10-K · filed 2024-02-28 |
| 2022-09-30 | $9.29M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $10.06M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $10.57M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $11.25M 10-K · filed 2023-02-28 |
| 2021-09-30 | $11.90M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $12.54M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $9.73M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $10.16M 10-K · filed 2022-02-28 |
| 2020-09-30 | $10.61M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $11.04M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $11.29M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $677.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $1.26M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.82M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.38M 10-Q · filed 2019-05-09 |